Navigation Links
Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
Date:5/15/2008

erate or severe nonhematologic toxicities, laboratory abnormalities, or concomitant use of strong CYP3A4 inhibitors. With concomitant use of strong CYP3A4 inducers, the dose of Tasigna may need to be increased, depending on patient tolerability.

Other patients in whom Tasigna should be used with caution: Tasigna should not be used during pregnancy. Sexually active female patients should use effective contraception during treatment. Women should not breast feed while taking Tasigna. There are no data to support the use of Tasigna in pediatric patients. Use with caution in patients with hepatic impairment.

Please see full Prescribing Information.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by terminology such as "pipeline", "to develop", "to highlight", "to feature", "to be", "will", "potential", or similar expressions, or by express or implied discussions regarding potential new products, potential new indications or labelling for existing products, or regarding potential future revenues from such products. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that any new products will be approved for sale in any market, or that any new indications or labelling will be approved for any existing products. Nor can there be any guarantee that any such products will achieve any particular levels of revenue in the future. In particular, management's expectations could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally;
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
2. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
3. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
4. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
5. Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
8. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007
9. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... NEW YORK , Aug. 20, ... a new market research report is ... The Market for Hospital-Acquired Infection Control ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html ... and healthcare-associated infections (HAIs), demand has ...
(Date:8/20/2014)... 20, 2014 Reportlinker.com announces that ... in its catalogue: Personal Accident ... and Opportunities to 2018 ... report provides in depth market analysis, information ... and health insurance segment, including: - The ...
(Date:8/20/2014)... , Aug. 20, 2014 Torrance ... be using advanced, ventilator technology from Covidien to ... care for patients. The acute ... naturally, compared to conventional mechanical ventilation, and help ... as possible. Patients on mechanical ventilation are often ...
Breaking Medicine Technology:The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 2Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 3Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 4Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 5Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 6Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 7Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 8Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 9Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 10Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 11Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 12Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 13Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 14Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 15Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 16Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 17Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 18Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 19Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 20Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 21Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 22Personal Accident and Health Insurance in France, Key Trends and Opportunities to 2018 23Torrance Memorial Medical Center Acquires Advanced Ventilator Technology to Enhance Patient Care 2
... Corporation (NASDAQ: DYNT ) today announced results for ... 2011. Sales for the quarter ended December 31, ... the quarter ended December 31, 2010. Sales for the six ... $16,272,232, compared to $16,118,635 for the six months ended December ...
... Company (Nasdaq: PRGO ; TASE) announced that ... tablets, the store brand equivalent to Schering-Plough,s Claritin-D® 12 ... is indicated for the treatment of nasal allergy symptoms. ... to data provided by Wolters, Kluwer. ...
Cached Medicine Technology:Dynatronics Announces Second Quarter Results 2Dynatronics Announces Second Quarter Results 3Dynatronics Announces Second Quarter Results 4Perrigo Announces the Launch of Loratadine-D 12 Store Brand Labels -- the First Store Brand Launch That Compares to Claritin-D® 12 2
(Date:8/21/2014)... York (PRWEB) August 21, 2014 According ... Research "Medical Fiber Optics Market-Global Industry Analysis, Size, Share, ... medical fiber optics market was valued at USD 863.1 ... a CAGR of 7.6% from 2013 to 2019, to ... 2019. , The medical fiber optics market is witnessing ...
(Date:8/21/2014)... The worlds of personal care and yoga ... to grab free products. BaliniSports will be ... Maine with all qualifying purchases for a limited time. ... yoga apparel is simply perfect,” said Ada Hung, founder ... two brands is intended to give people in the ...
(Date:8/21/2014)... 2014 David Mullings’ new book, Things ... powerful collection of quotes from famous entrepreneurs to the ... budding entrepreneurs on their challenging paths towards success. Earth ... inclusion of President and Founder Audrey Darrow alongside the ... self-made celebrities such as Oprah Winfrey, Steve Jobs, and ...
(Date:8/21/2014)... variant of fatty acid-binding protein 4 (FABP4), which ... of heart attack and stroke. The finding revealed ... preventive drug for atherosclerosis. , Led by ... the Department of Neurology at the Hospital District ... atherosclerosis. It is a joint effort involving the ...
(Date:8/21/2014)... researchers at the University of Montreal, the regions of ... as we train our bodies, movements and, critically, they ... researchers knew that sleep helped us the learn sequences ... "The subcortical regions are important in information consolidation, especially ... level is measured after a period of sleep, the ...
Breaking Medicine News(10 mins):Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4Health News:Tom's of Maine Partner up with BaliniSports Yoga Apparel 2Health News:Earth Source Organics President Audrey Darrow Featured in New David Mullings Book 2Health News:A novel pathway for prevention of heart attack and stroke 2Health News:Learning to play the piano? Sleep on it! 2
... say that plastic surgery was performed mainly on Hispanics, Blacks ... this surgery than any other community. It was mainly ... aging. ,Statistics show that more and more people ... million procedures performed. This was a whooping 65 % increase ...
... Tsang said that the public should be responsible and support all ... scare at bay. // ,He asked the public not ... provide timely warnings and emergency tackling plans. ,He said ... said that they should be well prepared to tackle a pandemic. ...
... Kuala Lumpur, Malaysia a two-year-old boy dies at the hospital after ... mouth disease (HFMD). // , This happened in Sarawak ... including the death of the boy. , The child ... hospital. ,Deputy State Chief Minister George Chan said ...
... a 500-capacity British cruise vessel, Funchal that has been around ... the West Australian coast, and will host the medical team, ... been infected by a contagious flu. ,The department's director ... Department of Health is sending a team of specialists to ...
... a Low GI diet, do a rethink. Glycaemic index as a ... ,It is an indicator of sugar in foods. High-GI foods, ... in blood sugar, and some studies have suggested that diets heavy ... disease. ,Still, a direct relation and associations between high-GI foods ...
... of Madhya Pradesh, which has been facing the death of ... has alerted the authorities, who in turn has started investigating ... ,Suraj Damor, the district magistrate of Burhanpur, said 80 ... ,Other reports, however, said some 400 chickens had died ...
Cached Medicine News:Health News:Bird Flu Fear Grips Madhya Pradesh 2
...
Tryptone is the pancreatic digest of casein used as a nitrogen source for bacteria. Ideal for general bacteriological use with a variety of microorganisms. Tryptone is guaranteed BSE-Free....
... 10k units Pen.,10k ug Strept. ... Cell Culture Reagent and Buffer ... with cGMP regulations and are ... compatibility. , Typical Properties, Sterility ...
... (Penicillin G) inhibits bacterial ... synthesis. Streptomycin belongs to ... inhibits bacterial growth by ... is used for prevention ...
Medicine Products: